Patent application number | Description | Published |
20090087490 | EXTENDED RELEASE FORMULATION AND METHOD OF TREATING ADRENERGIC DYSREGULATION - A composition and method of treating adrenergic dysregulation by administering the composition is disclosed, wherein the composition comprises a α | 04-02-2009 |
20100063123 | EXTENDED RELEASE FORMULATION AND METHOD OF TREATING ADRENERGIC DYSREGULATION - A composition and method of treating adrenergic dysregulation by administering the composition is disclosed, wherein the composition comprises a a2-adrenergic receptor agonist; a pharmaceutically acceptable hydrophilic matrix and a release-retardant of a metal alkyl sulfate. In embodiments, the composition provides a sustained release of the agonist, wherein after administration of the composition no more than once about every 12 hours to a subject having a steady state plasma concentration of the a2-adrenergic receptor agonist, the agonist's plasma concentration peak-to-trough ratio is no greater than about 1.9. | 03-11-2010 |
20100172991 | Extended Release Formulation and Methods of Treating Adrenergic Dysregulation - A composition and method of treating adrenergic dysregulation by administering the composition is disclosed, wherein the composition comprises a α | 07-08-2010 |
20110245314 | Extended Release Formulation and Methods of Treating Adrenergic Dysregulation - A composition and method of treating adrenergic dysregulation by administering the composition is disclosed, wherein the composition comprises a α | 10-06-2011 |
20120142769 | METHODS FOR TREATING OR PREVENTING FATIGUE - The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments. | 06-07-2012 |
20120252793 | INTRANASAL BENZODIAZEPINE PHARMACEUTICAL COMPOSITIONS - The present invention generally relates to intranasal pharmaceutical compositions comprising a benzodiazepine and methods of use thereof that can provide a therapeutic effect without a decrease in blood pressure and/or pulse after administration of the pharmaceutical composition. | 10-04-2012 |
20140128381 | Intranasal Benzodiazepine Pharmaceutical Compositions - The present invention generally relates to intranasal pharmaceutical compositions comprising a benzodiazepine and methods of use thereof that can provide a therapeutic effect without a decrease in blood pressure and/or pulse after administration of the pharmaceutical composition. | 05-08-2014 |
20140243406 | Methods for Treating or Preventing Fatigue - The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments. | 08-28-2014 |
20140275244 | Treatment of Cataplexy - The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. | 09-18-2014 |
20150018414 | Promotion of Smoking Cessation - The present invention relates to a method for promoting cessation or reduction in the smoking and/or chewing of tobacco or nicotine-containing products in a subject in need thereof, comprising administering to the subject an effective amount of certain carbamate compounds. The invention further relates to a method for preventing relapse smoking and/or chewing of tobacco or nicotine-containing products in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. | 01-15-2015 |
20150025136 | Treatment for Obesity - The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. | 01-22-2015 |